BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $218 | -99.9% | 4,029 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $218,000 | -8.0% | 4,029 | +9.3% | 0.01% | +7.7% |
| Q2 2022 | $237,000 | -20.7% | 3,686 | -4.3% | 0.01% | -13.3% |
| Q1 2022 | $299,000 | -29.1% | 3,851 | -21.4% | 0.02% | -28.6% |
| Q4 2021 | $422,000 | +6.8% | 4,902 | +0.0% | 0.02% | -8.7% |
| Q3 2021 | $395,000 | +9.1% | 4,900 | +9.2% | 0.02% | 0.0% |
| Q2 2021 | $362,000 | -4.5% | 4,486 | -0.0% | 0.02% | -11.5% |
| Q1 2021 | $379,000 | +30.7% | 4,488 | +24.5% | 0.03% | +18.2% |
| Q4 2020 | $290,000 | -7.6% | 3,606 | -7.4% | 0.02% | -18.5% |
| Q3 2020 | $314,000 | +4.0% | 3,895 | +11.1% | 0.03% | 0.0% |
| Q2 2020 | $302,000 | +8.6% | 3,506 | +2.6% | 0.03% | -10.0% |
| Q1 2020 | $278,000 | -2.8% | 3,418 | 0.0% | 0.03% | +20.0% |
| Q4 2019 | $286,000 | -1.7% | 3,418 | +2.7% | 0.02% | -16.7% |
| Q3 2019 | $291,000 | +3.9% | 3,328 | -2.6% | 0.03% | 0.0% |
| Q2 2019 | $280,000 | -5.7% | 3,418 | -6.3% | 0.03% | -9.1% |
| Q1 2019 | $297,000 | +40.8% | 3,647 | +13.7% | 0.03% | +10.0% |
| Q4 2018 | $211,000 | -3.7% | 3,208 | +12.5% | 0.03% | -30.2% |
| Q3 2018 | $219,000 | +3.3% | 2,851 | -1.1% | 0.04% | -6.5% |
| Q2 2018 | $212,000 | -32.5% | 2,882 | -40.5% | 0.05% | -35.2% |
| Q1 2018 | $314,000 | +0.6% | 4,842 | 0.0% | 0.07% | -2.7% |
| Q4 2017 | $312,000 | +3.0% | 4,842 | 0.0% | 0.07% | -14.1% |
| Q3 2017 | $303,000 | +51.5% | 4,842 | +46.0% | 0.08% | +34.9% |
| Q2 2017 | $200,000 | -43.2% | 3,317 | -51.3% | 0.06% | -28.4% |
| Q1 2017 | $352,000 | – | 6,805 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |